Recruitment

Recruitment Status
Terminated
Estimated Enrollment
54

Inclusion Criterias

Age, between 19 and 75
Stage III (according to the AJCC 7th criteria)
Histologically proven advanced gastric cancer
...
Age, between 19 and 75
Stage III (according to the AJCC 7th criteria)
Histologically proven advanced gastric cancer
ECOG status 0 to 2
R0 resection after D2 gastrectomy

Exclusion Criterias

Previous chemotherapy history for gastric cancer
Inadequate condition for receiving chemotherapy due to significant systemic disease
Malignancy history other than gastric cancer
...
Previous chemotherapy history for gastric cancer
Inadequate condition for receiving chemotherapy due to significant systemic disease
Malignancy history other than gastric cancer
Severe renal dysfunction
Pregnancy or breast milk feeding
Significant neurologic or psychologic disease
Patients who receives drugs which can be interacted with S-1
Severe hepatic dysfunction
Severe bone marrow dysfunction
Previous radiotherapy history for gastric cancer
Active infection
Grade 3 or more of neuropathy

Summary

Conditions
Advanced Gastric Cancer
Type
Interventional
Phase
Phase 2
Design
  • Allocation: N/A
  • Intervention Model: Single Group Assignment
  • Masking: None (Open Label)
  • Primary Purpose: Treatment

Participation Requirements

Age
Between 19 years and 75 years
Gender
Both males and females

Inclusion Criterias

Age, between 19 and 75
Stage III (according to the AJCC 7th criteria)
Histologically proven advanced gastric cancer
...
Age, between 19 and 75
Stage III (according to the AJCC 7th criteria)
Histologically proven advanced gastric cancer
ECOG status 0 to 2
R0 resection after D2 gastrectomy

Exclusion Criterias

Previous chemotherapy history for gastric cancer
Inadequate condition for receiving chemotherapy due to significant systemic disease
Malignancy history other than gastric cancer
...
Previous chemotherapy history for gastric cancer
Inadequate condition for receiving chemotherapy due to significant systemic disease
Malignancy history other than gastric cancer
Severe renal dysfunction
Pregnancy or breast milk feeding
Significant neurologic or psychologic disease
Patients who receives drugs which can be interacted with S-1
Severe hepatic dysfunction
Severe bone marrow dysfunction
Previous radiotherapy history for gastric cancer
Active infection
Grade 3 or more of neuropathy

Locations

Seoul, 120-752
Seoul, 120-752

Tracking Information

NCT #
NCT01946061
Collaborators
Not Provided
Investigators
Not Provided